Previous reports demonstrated some factors, such as Neuropilin-1 (NRP1) (10) and enhancer of zeste homolog 2 (EZH2) (11), restrictively deleted in Tregs impaired the transcription activity of FOXP3, restricting Treg-suppressive ability and conferring resistance to tumor growth in the host. This evidence concerns the gene FOXP3 and neoplasm.